Serum antiretinal antibodies and cytokine profiling in autoimmune retinopathy and their association with clinical outcomes

[1]  D. Grewal,et al.  Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema. , 2021, Ophthalmology. Retina.

[2]  Shruti Gupta,et al.  Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm , 2021, Indian Journal of Clinical Biochemistry.

[3]  J. Pulido,et al.  Clinical Utility of Antiretinal Antibody Testing. , 2021, JAMA ophthalmology.

[4]  B. Jeffrey,et al.  Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial , 2020, Taiwan journal of ophthalmology.

[5]  L. Sobrin,et al.  Correlation of Immunological Markers with Disease and Clinical Outcome Measures in Patients with Autoimmune Retinopathy , 2020, Translational vision science & technology.

[6]  Sufang Yang,et al.  Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. , 2019, Clinical immunology.

[7]  L. Sobrin,et al.  Lack of Correlation between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients. , 2019, Ophthalmology. Retina.

[8]  Xiaoyan Peng,et al.  Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  R. Tagett,et al.  T Helper 1 Cellular Immunity Toward Recoverin Is Enhanced in Patients With Active Autoimmune Retinopathy , 2018, Front. Med..

[10]  G. Adamus.  Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies? , 2018, Front. Immunol..

[11]  S. Gangaputra,et al.  Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients , 2017, Journal of Neuroimmunology.

[12]  S. Davoudi,et al.  Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab. , 2017, American journal of ophthalmology.

[13]  J. P. McCoy,et al.  B Cell Anomalies in Autoimmune Retinopathy (AIR) , 2017, Investigative ophthalmology & visual science.

[14]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[15]  J. Heckenlively,et al.  Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach. , 2016, American journal of ophthalmology.

[16]  F. Forooghian.  The Uncertainty Regarding Antiretinal Antibodies. , 2015, JAMA ophthalmology.

[17]  A. Kanda,et al.  A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase , 2014, BMC Ophthalmology.

[18]  E. Rahimy,et al.  Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. , 2013, Survey of ophthalmology.

[19]  G. Adamus,et al.  Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats , 2013, Journal of Neuroimmunology.

[20]  R. Nussenblatt,et al.  Autoimmune retinopathy. , 2014, American journal of ophthalmology.